Chemoinformaics analysis of 2-(Chloromethyl)-2,3-dihydro-4(1H)-quinolinone
Molecular Weight | 195.649 | nRot | 1 |
Heavy Atom Molecular Weight | 185.569 | nRig | 12 |
Exact Molecular Weight | 195.045 | nRing | 2 |
Solubility: LogS | -3.644 | nHRing | 1 |
Solubility: LogP | 2.56 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 27.4499 |
nHD | 1 | BPOL | 11.9801 |
QED | 0.697 |
Synth | 3.018 |
Natural Product Likeliness | 0.226 |
NR-PPAR-gamma | 0.067 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.003 |
HIA | 0.006 |
CACO-2 | -4.811 |
MDCK | 0.0000734 |
BBB | 0.988 |
PPB | 0.587317 |
VDSS | 1.078 |
FU | 0.365344 |
CYP1A2-inh | 0.903 |
CYP1A2-sub | 0.875 |
CYP2c19-inh | 0.723 |
CYP2c19-sub | 0.24 |
CYP2c9-inh | 0.356 |
CYP2c9-sub | 0.443 |
CYP2d6-inh | 0.236 |
CYP2d6-sub | 0.859 |
CYP3a4-inh | 0.346 |
CYP3a4-sub | 0.179 |
CL | 6.429 |
T12 | 0.647 |
hERG | 0.041 |
Ames | 0.909 |
ROA | 0.651 |
SkinSen | 0.291 |
Carcinogencity | 0.843 |
EI | 0.367 |
Respiratory | 0.843 |
NR-Aromatase | 0.014 |
Antiviral | No |
Prediction | 0.872285 |